MedTrace Logo

NeoMatriX Wound Matrix Collagen Dressing Skin Prick Test

NCT03522675 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2019-05-31

Study results available
· View outcomes & findings →

Summary

The objective of this study is to investigate the potential of NeoMatriXTM Wound Matrix to cause an allergic response to healthy volunteers using a skin prick test.

Conditions

  • Allergy Skin
  • Allergy
  • Dermatitis, Allergic Contact

Interventions

DEVICE

NeoMatriX Wound MatriX Collagen Dressing

Collagen wound dressing

Sponsors & Collaborators

  • State University of New York at Buffalo

    collaborator OTHER

  • NeXtGen Biologics, Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-11
Primary Completion
2018-04-26
Completion
2018-04-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03522675 on ClinicalTrials.gov